ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development
Industry News: ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development
The partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics
07 Apr 2021
Viroclinics-DDL, a state-of-the-art contract research organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, have announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.
This R&D partnership project combines wet-lab (in vitro) diagnostic and high-throughput sequencing expertise of Viroclinics-DDL and dry-lab (in silico) bioinformatics and immunomics knowledge of ENPICOM.